Best Time to Take Retatrutide (Morning or Night?)

The best time to take retatrutide is whatever hour you can repeat on the same day each week. It's a once-weekly shot with a half-life of about 6 days and a peak blood level within 12 to 72 hours of the dose, so a morning shot and a bedtime shot leave about the same amount of drug working over the week. No retatrutide trial has compared times of day, and the labels for tirzepatide and semaglutide, its closest relatives, say "any time of day, with or without meals."

Retatrutide isn't approved anywhere, so there's no retatrutide label telling you when to inject. Lilly last said, on September 29, 2026, that it plans to submit retatrutide to the FDA in the first quarter of 2027 as a Biologics License Application (BLA). On October 2, 2026, the FDA decided that retatrutide is a drug, not a biological product, so an application would need to be filed under section 505 of the Federal Food, Drug, and Cosmetic Act. Lilly's appeal on that question is pending in the Seventh Circuit, and we found no ruling as of October 31, 2026.

Is there a best time to take retatrutide?

Not by the clock. Lilly's FAQ describes retatrutide in its trials as a once-weekly injection under the skin, and the public trial records add little to that. The ClinicalTrials.gov entry for TRIUMPH-1, Lilly's main Phase 3 obesity trial, lists the drug as "Administered SC" and says nothing about the hour or meals. We checked the Phase 2 obesity trial and TRIUMPH-4 records too and found the same, most recently on October 31, 2026.

The closest official guidance comes from drugs in the same family. Here is what their labels say, set against what's known for retatrutide.

The tirzepatide and semaglutide columns come from the Zepbound, Mounjaro and Wegovy prescribing information on DailyMed. They're class evidence, not retatrutide data. The retatrutide peak comes from Lilly Medical Information, which lists a range and no median.

The Wegovy label goes one step further than the others: "The time of day and the injection site can be changed without the need for a dosage modification." That's semaglutide, but the logic holds for any weekly shot that lingers for days. Where to inject is its own topic, on the how to inject retatrutide page.

Why the hour barely matters

With a half-life of about 6 days, 44.5% of a dose is still in your body a week later, by our math, and the next shot lands on top of it. The chart shows how slowly a single dose fades, and the retatrutide half-life page has the longer version.

Move the shot from 8 am to 8 pm on the same day and you add 12 hours to one gap. By the same arithmetic, the leftover from your previous dose drops from 44.5% to 42.0% on that one occasion, and the week after you're back in rhythm. These figures assume simple clearance and ignore the slow absorption from under the skin, which spreads each dose out, so they probably overstate the difference.

Our read: a one-off dip of 2.5 points isn't a reason to favor one hour over another, so the best hour is the one you'll actually hit every week.

Can you take reta at night or before bed?

Yes. Nothing in the trial records or the related labels rules out an evening or bedtime shot.

One argument for a night shot is that you sleep through the nausea. Lilly's range for the peak doesn't support that. Blood levels peak within 12 to 72 hours of dosing, and the table shows where that window falls for three shot times.

These are our calculations from Lilly's range. Individual peaks aren't published, and we found no retatrutide data that ties nausea to a time after the shot.

Our read: even the earliest end of the range puts a 10 pm shot's peak at 10 am, after your alarm. A 60-hour window is also wider than the 14 hours between a morning shot and a bedtime one, so moving the shot doesn't buy a reliably quiet peak. For ways to ease the queasy days themselves, see our retatrutide nausea guide.

Sleep problems don't stand out in the Phase 2 obesity trial, where insomnia didn't reach the 5% reporting threshold in any dose group, and we found no Phase 3 figure. If you do sleep badly on it, our retatrutide insomnia page goes through the likely causes, including nighttime reflux and evening fluids.

When does reta kick in after injection?

Blood levels peak within 12 to 72 hours of a dose, according to Lilly Medical Information. Lilly gives no median, and its page cites Phase 1 work. For tirzepatide the label gives a median of 24 hours, which is class evidence and shouldn't be borrowed for retatrutide.

Feeling it and peaking are different things, and one shot lasts. In Lilly's Phase 1 single-dose study, weight reduction persisted up to day 43 after a single injection, according to the 2022 Cell Metabolism paper. For tirzepatide, the label says steady blood levels arrive after 4 weekly doses, which is class evidence. A common rule of thumb is about 5 half-lives, which for 6 days is around 30 days, so retatrutide may follow a similar build-up. That's our arithmetic, not a trial result.

Weight comes off over months, not days. For how that looked in the trials, week by week, see retatrutide weight loss results.

Picking your injection day

The day matters more than the hour, mostly because of dose increases. In the Phase 3 TRIUMPH trials, everyone on retatrutide started at 2 mg (more on that in the starting dose guide) and stepped up every 4 weeks. In TRANSCEND-T2D-1, Lilly reported that nausea, diarrhea and vomiting happened mainly during that escalation, and the tirzepatide label says the same about its own ramp. In TRIUMPH-1, about 4 in 10 people on 12 mg (42.4%) had nausea at some point over 80 weeks, against 14.8% on placebo.

So plan around the days after a step up. Nothing we found ties nausea to a particular hour, and a peak that can land up to three days out means no single evening is reliably safe, so the window to protect is longer than one night. The full ramp, with the missed-dose rules borrowed from related labels, is on the retatrutide dosing schedule page, and the step sizes are in the dosage chart. If you're coming over from tirzepatide, the switching guide shows how much of your last shot is still in your body when you start.

One timing rule does have class evidence behind it. The tirzepatide label tells people on birth control pills to switch to a non-oral method, or add a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase. Lilly finished a retatrutide study with an oral contraceptive in July 2024 but, as of October 2026, hasn't posted results, so nobody knows yet whether the same applies. More on that is on the pregnancy and fertility page.

Moving your day, travel and late shots

The tirzepatide label lets you change your weekly day as long as doses stay at least 72 hours apart. The Wegovy guide asks for 2 or more days since the last dose. Retatrutide has no rule. Here's what a change does to the leftover from your previous shot, using the 6-day half-life.

These are our calculations from the Phase 1b half-life, with absorption ignored. They're not measured blood levels.

A time-zone trip barely registers, so you can dose at the usual local hour. Moving the day earlier packs two doses close together, and both labels set a minimum gap for that move, while moving it later lets levels dip for one week. No retatrutide trial has tested either move, so agree a day change with your prescriber. If you're carrying a pen or mixed vial, the storage guide covers keeping it cold on the road.

Timing can't fix a wrong dose

Every number on this page assumes the vial holds what its label says. Lilly's October 2026 FAQ says retatrutide "has not been reviewed or approved by the FDA or any regulatory agency in the world, and no one can legally sell it for human use," so anything sold online isn't Lilly's product. When Australia's TGA tested a vial sold as retatrutide after a serious adverse event report, it held no retatrutide at all, only undeclared semaglutide at about 8 times the level in approved products. Victoria's health department has reported 6 cases of acute liver injury since January 2026 in people who used products labeled as retatrutide. If you're weighing retatrutide for sale listings anyway, that page covers batch test reports and the red flags to check first.

A misread syringe also moves your dose far more than any injection hour. The retatrutide units page turns milligrams into syringe markings, and the retatrutide calculator does the math for your vial.